Chimera Investment (CIM)
(Delayed Data from NYSE)
$14.99 USD
+0.28 (1.90%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $14.98 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum F VGM
Chimera Investment (CIM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$16.50 | $18.00 | $15.00 | 12.17% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Chimera Investment comes to $16.50. The forecasts range from a low of $15.00 to a high of $18.00. The average price target represents an increase of 12.17% from the last closing price of $14.71.
Analyst Price Targets (3 )
Broker Rating
Chimera Investment currently has an average brokerage recommendation (ABR) of 2.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 2.80 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, one is Buy, representing 20% of all recommendations. A month ago, Buy represented 20%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/CIM.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.80 | 2.80 | 2.80 | 2.80 | 2.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/10/2024 | Keefe Bruyette & Woods | Bose T George | Hold | Hold |
2/22/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
1/2/2024 | BTIG | Eric J Hagen | Not Available | Hold |
12/6/2023 | UBS | Douglas Harter | Not Available | Hold |
11/6/2023 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.80 |
ABR (Last week) | 2.80 |
# of Recs in ABR | 5 |
Average Target Price | $16.50 |
LT Growth Rate | NA |
Industry | REIT and Equity Trust |
Industry Rank by ABR | 199 of 252 |
Current Quarter EPS Est: | 0.34 |